Select a Region North America

Strategies to Ensure Market Success of a Rare Disease Product Launch

Small patient populations, complex administration, high costs of therapies, and government policy interventions are just a few obstacles in rare disease.

EVERSANA’s Managing Director, Bill O’Bryon, and Senior Director, Diann Johnson, outline key insights to consider in your launch strategy:

  1. Market dynamics impacting rare disease therapies
  2. The entire rare community: patients, caregivers, providers & advocates
  3. Payer landscape and engagement
  4. Patient experience
  5. Stakeholder relationships

Watch the Webinar: Strategies to Ensure Market Success of a Rare Disease Product Launch

Author Team
no-image

EVERSANA employs a team of over 6000 professionals across 20+ locations around the world. From industry-leading patient service and adherence support to global pricing and revenue management, our team informs the strategies that matter…